<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Charles Rabolli</title><link>http://charlesrabolli.com/</link><atom:link href="http://charlesrabolli.com/index.xml" rel="self" type="application/rss+xml"/><description>Charles Rabolli</description><generator>Hugo Blox Builder (https://hugoblox.com)</generator><language>en-us</language><lastBuildDate>Mon, 24 Oct 2022 00:00:00 +0000</lastBuildDate><image><url>http://charlesrabolli.com/media/icon_hu7729264130191091259.png</url><title>Charles Rabolli</title><link>http://charlesrabolli.com/</link></image><item><title>AI Foundation Models for Digital Pathology</title><link>http://charlesrabolli.com/project/ai-digital-pathology/</link><pubDate>Mon, 01 Sep 2025 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/project/ai-digital-pathology/</guid><description>&lt;p>As part of the AI Lab for Pathology Research (AI4Path) at The Ohio State University, I am contributing to the development of next-generation AI foundation models for computational pathology. This work involves:&lt;/p>
&lt;ul>
&lt;li>Training large-scale vision foundation models on whole-slide histology images&lt;/li>
&lt;li>Curating and annotating colorectal carcinoma slides to generate high-quality training data&lt;/li>
&lt;li>Applying deep learning to enable scalable, intelligent interpretation of digital pathology images&lt;/li>
&lt;li>Bridging molecular biology expertise with machine learning to enhance diagnostic accuracy&lt;/li>
&lt;/ul>
&lt;p>This research sits at the intersection of medicine, engineering, and AI — translating cutting-edge machine learning into real-world diagnostic tools.&lt;/p></description></item><item><title>Joined AI4Path Lab — AI for Pathology Research at OSU</title><link>http://charlesrabolli.com/post/ai4path-position-2025/</link><pubDate>Mon, 01 Sep 2025 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/post/ai4path-position-2025/</guid><description>&lt;p>Excited to join the AI Lab for Pathology Research (AI4Path) at The Ohio State University. In this role I am developing next-generation AI foundation models for pathology, leveraging large-scale histology datasets to transform diagnostic workflows. I am also curating and annotating colorectal carcinoma slides to generate high-quality training data for scalable, intelligent interpretation of digital pathology images.&lt;/p></description></item><item><title>New Paper: AIMP3 in Cardiac Homeostasis — Nature Cardiovascular Research</title><link>http://charlesrabolli.com/post/nature-cardiovascular-aimp3-2025/</link><pubDate>Tue, 01 Jul 2025 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/post/nature-cardiovascular-aimp3-2025/</guid><description>&lt;p>Proud to share a new paper in &lt;em>Nature Cardiovascular Research&lt;/em>! &amp;ldquo;AIMP3 maintains cardiac homeostasis by regulating the editing activity of methionyl-tRNA synthetase&amp;rdquo; — uncovering a novel mechanism by which aminoacyl-tRNA synthesis quality control shapes cardiac function. &lt;a href="https://pubmed.ncbi.nlm.nih.gov/40562875/" target="_blank" rel="noopener">Read it on PubMed&lt;/a>.&lt;/p></description></item><item><title>New Paper: YTHDF3 Modulates Cardiac Response to Stress — RNA Journal</title><link>http://charlesrabolli.com/post/rna-ythdf3-2025/</link><pubDate>Sun, 01 Jun 2025 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/post/rna-ythdf3-2025/</guid><description>&lt;p>New paper published in &lt;em>RNA&lt;/em>! &amp;ldquo;The m6A-binding protein YTHDF3 modulates the cardiac response to stress&amp;rdquo; — establishing YTHDF3 as a key regulator of cardiac remodeling under stress conditions. &lt;a href="https://pubmed.ncbi.nlm.nih.gov/40216557/" target="_blank" rel="noopener">Read it on PubMed&lt;/a>.&lt;/p></description></item><item><title>PhD Completed — Biomedical Engineering, The Ohio State University</title><link>http://charlesrabolli.com/post/phd-completed-2025/</link><pubDate>Thu, 01 May 2025 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/post/phd-completed-2025/</guid><description>&lt;p>Thrilled to share that I have successfully completed my PhD in Biomedical Engineering at The Ohio State University as part of the Medical Scientist Training Program (MSTP). My thesis, &lt;em>RNA Modifications (Epitranscriptome) in the maintenance of cardiac homeostasis&lt;/em>, explored how m6A RNA methylation shapes cardiac function, metabolism, and remodeling — using molecular biology, mouse models, nanopore sequencing, and multi-omics approaches. Supervised by &lt;a href="https://accornerolab.com" target="_blank" rel="noopener">Prof. Federica Accornero&lt;/a>.&lt;/p></description></item><item><title>New Paper: Cardiac METTL3/m6A Pathway and Systemic Response to Western Diet — JCI Insight</title><link>http://charlesrabolli.com/post/jci-insight-mettl3-2025/</link><pubDate>Tue, 01 Apr 2025 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/post/jci-insight-mettl3-2025/</guid><description>&lt;p>New paper out in &lt;em>JCI Insight&lt;/em>! &amp;ldquo;The cardiac METTL3/m6A pathway regulates the systemic response to Western diet&amp;rdquo; — a study revealing how m6A RNA methylation in the heart shapes systemic metabolic function. &lt;a href="https://pubmed.ncbi.nlm.nih.gov/40272887/" target="_blank" rel="noopener">Read it on PubMed&lt;/a>.&lt;/p></description></item><item><title>AIMP3 maintains cardiac homeostasis by regulating the editing activity of methionyl-tRNA synthetase</title><link>http://charlesrabolli.com/publication/das_aimp3_2025/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/das_aimp3_2025/</guid><description/></item><item><title>The cardiac METTL3/m6A pathway regulates the systemic response to Western diet</title><link>http://charlesrabolli.com/publication/rabolli_cardiac_mettl3_2025/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/rabolli_cardiac_mettl3_2025/</guid><description/></item><item><title>The m6A-binding protein YTHDF3 modulates the cardiac response to stress</title><link>http://charlesrabolli.com/publication/rabolli_ythdf3_2025/</link><pubDate>Wed, 01 Jan 2025 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/rabolli_ythdf3_2025/</guid><description/></item><item><title>Projects</title><link>http://charlesrabolli.com/projects/</link><pubDate>Sun, 19 May 2024 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/projects/</guid><description/></item><item><title>Oral Presentation — American College of Cardiology Scientific Sessions 2024</title><link>http://charlesrabolli.com/event/acc-scientific-sessions-2024/</link><pubDate>Sat, 06 Apr 2024 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/event/acc-scientific-sessions-2024/</guid><description>&lt;p>Presented oral research on the cardiac METTL3/m6A pathway and its regulation of systemic metabolic response to Western diet at the American College of Cardiology Scientific Sessions 2024 in Atlanta, GA.&lt;/p></description></item><item><title>Cardiac cryptographers: cracking the code of the epitranscriptome</title><link>http://charlesrabolli.com/publication/rabolli_cardiac_2024/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/rabolli_cardiac_2024/</guid><description/></item><item><title>CITED4 gene therapy protects against maladaptive cardiac remodeling after ischemia/reperfusion injury in mice</title><link>http://charlesrabolli.com/publication/lerchenmuller_cited4_2024/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/lerchenmuller_cited4_2024/</guid><description/></item><item><title>In vitro inflammatory multi-cellular model of osteoarthritis</title><link>http://charlesrabolli.com/publication/marrero-berrios_vitro_2024/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/marrero-berrios_vitro_2024/</guid><description/></item><item><title>Nanopore Detection of METTL3-Dependent m6A-Modified mRNA Reveals a New Mechanism Regulating Cardiomyocyte Mitochondrial Metabolism</title><link>http://charlesrabolli.com/publication/rabolli_nanopore_2024/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/rabolli_nanopore_2024/</guid><description/></item><item><title>YTHDF1 is pivotal for maintenance of cardiac homeostasis</title><link>http://charlesrabolli.com/publication/golubeva_ythdf1_2024/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/golubeva_ythdf1_2024/</guid><description/></item><item><title>YTHDF2 governs muscle size through a targeted modulation of proteostasis</title><link>http://charlesrabolli.com/publication/gilbert_ythdf2_2024/</link><pubDate>Mon, 01 Jan 2024 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/gilbert_ythdf2_2024/</guid><description/></item><item><title>Experience</title><link>http://charlesrabolli.com/experience/</link><pubDate>Tue, 24 Oct 2023 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/experience/</guid><description/></item><item><title>Poster Presentation — AHA Basic Cardiovascular Sciences 2023</title><link>http://charlesrabolli.com/event/ahf-basic-cardiovascular-sciences-2023/</link><pubDate>Mon, 10 Jul 2023 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/event/ahf-basic-cardiovascular-sciences-2023/</guid><description>&lt;p>Presented research on YTHDF3-mediated post-transcriptional regulation in the cardiac response to pressure overload at the AHA Basic Cardiovascular Sciences Scientific Sessions 2023.&lt;/p></description></item><item><title>Awarded NIH F30 Individual Predoctoral Fellowship (F30HL165812)</title><link>http://charlesrabolli.com/post/nih-f30-award-2023/</link><pubDate>Sat, 01 Jul 2023 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/post/nih-f30-award-2023/</guid><description>&lt;p>Honored to receive an NIH F30 Individual Predoctoral Fellowship (F30HL165812) from the National Heart, Lung, and Blood Institute. This award supports my research investigating the role of the N6-methyladenosine (m6A) binding protein YTHDF3 in the cardiovascular system, funded 2023–2026. &lt;a href="https://reporter.nih.gov/search/lMvL_0QI-0ieR4uiD1ouRg/project-details/10676427" target="_blank" rel="noopener">View on NIH Reporter&lt;/a>.&lt;/p></description></item><item><title>Loss of YTHDF2 Alters the Expression ofÂ m6A-Modified Myzap and Causes Adverse Cardiac Remodeling</title><link>http://charlesrabolli.com/publication/golubeva_loss_2023/</link><pubDate>Sun, 01 Jan 2023 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/golubeva_loss_2023/</guid><description/></item><item><title>Poster Presentation — AHA Scientific Sessions 2022</title><link>http://charlesrabolli.com/event/aha-scientific-sessions-2022/</link><pubDate>Sat, 05 Nov 2022 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/event/aha-scientific-sessions-2022/</guid><description>&lt;p>Presented research on the role of the m6A epitranscriptome in cardiac remodeling at the American Heart Association Scientific Sessions 2022 in Chicago, IL.&lt;/p></description></item><item><title>m6A RNA methylation: A dynamic regulator of cardiac muscle and extracellular matrix</title><link>http://charlesrabolli.com/publication/rabolli_m6a_2022/</link><pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/rabolli_m6a_2022/</guid><description/></item><item><title>Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy</title><link>http://charlesrabolli.com/publication/howard_mineralocorticoid_2022/</link><pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/howard_mineralocorticoid_2022/</guid><description/></item><item><title>Restoration of Cardiomyogenesis in Aged Mouse Hearts by Voluntary Exercise</title><link>http://charlesrabolli.com/publication/lerchenmuller_restoration_2022/</link><pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/lerchenmuller_restoration_2022/</guid><description/></item><item><title>m6A Epitranscriptomics in the Heart</title><link>http://charlesrabolli.com/project/epitranscriptomics-heart/</link><pubDate>Mon, 01 Mar 2021 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/project/epitranscriptomics-heart/</guid><description>&lt;p>My doctoral research focused on how N6-methyladenosine (m6A) — the most abundant internal modification on mRNA — shapes cardiac function, metabolism, and remodeling. Using mouse models, molecular biology, nanopore sequencing, and multi-omics, we revealed that:&lt;/p>
&lt;ul>
&lt;li>&lt;strong>METTL3&lt;/strong>, the primary m6A methyltransferase, is required for normal cardiac metabolism and shapes the systemic response to a Western diet (&lt;em>JCI Insight&lt;/em>, 2025)&lt;/li>
&lt;li>&lt;strong>YTHDF2&lt;/strong>, an m6A reader, regulates cardiomyocyte survival and stress response (&lt;em>Circulation&lt;/em>, 2024)&lt;/li>
&lt;li>&lt;strong>YTHDF3&lt;/strong>, another m6A reader, modulates the cardiac hypertrophic response to pressure overload (&lt;em>RNA&lt;/em>, 2025)&lt;/li>
&lt;/ul>
&lt;p>This work established the cardiac m6A epitranscriptome as a critical layer of post-transcriptional gene regulation in heart health and disease.&lt;/p></description></item><item><title>CITED4 Protects Against Adverse Remodeling in Response to Physiological and Pathological Stress</title><link>http://charlesrabolli.com/publication/lerchenmuller_cited4_2020/</link><pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/lerchenmuller_cited4_2020/</guid><description/></item><item><title>Alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy</title><link>http://charlesrabolli.com/publication/davis_alginate_2019/</link><pubDate>Tue, 01 Jan 2019 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/davis_alginate_2019/</guid><description/></item><item><title>Cardiac Regeneration &amp; Drug Discovery</title><link>http://charlesrabolli.com/project/cardiac-regeneration/</link><pubDate>Mon, 01 Oct 2018 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/project/cardiac-regeneration/</guid><description>&lt;p>As a Fulbright U.S. Student Scholar at the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Trieste, Italy, I worked in the Giacca Lab on cardiac regeneration. This project involved:&lt;/p>
&lt;ul>
&lt;li>Utilizing a high-throughput, image-based drug screening platform with FDA-approved compound libraries&lt;/li>
&lt;li>Identifying agents that enhance cardiomyocyte proliferation and regeneration&lt;/li>
&lt;li>Integrating cell culture, histology, and molecular biology to validate candidate compounds&lt;/li>
&lt;li>Uncovering mechanisms driving cardiac repair after injury&lt;/li>
&lt;/ul>
&lt;p>This work contributed to the growing effort to find pharmacological strategies for regenerating the adult mammalian heart after myocardial infarction.&lt;/p></description></item><item><title>Exercise induces new cardiomyocyte generation in the adult mammalian heart</title><link>http://charlesrabolli.com/publication/vujic_exercise_2018/</link><pubDate>Mon, 01 Jan 2018 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/vujic_exercise_2018/</guid><description/></item><item><title>Elastin-like polypeptides: A strategic fusion partner for biologics</title><link>http://charlesrabolli.com/publication/yeboah_elastin-like_2016/</link><pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate><guid>http://charlesrabolli.com/publication/yeboah_elastin-like_2016/</guid><description/></item></channel></rss>